Elevance Health, Inc. (NYSE:ELV) Shares Sold by Auxier Asset Management

Auxier Asset Management cut its stake in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 4.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 35,642 shares of the company's stock after selling 1,573 shares during the quarter. Elevance Health accounts for about 2.0% of Auxier Asset Management's investment portfolio, making the stock its 9th largest holding. Auxier Asset Management's holdings in Elevance Health were worth $13,148,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of the stock. Atomi Financial Group Inc. raised its position in shares of Elevance Health by 6.8% in the 4th quarter. Atomi Financial Group Inc. now owns 657 shares of the company's stock worth $243,000 after acquiring an additional 42 shares in the last quarter. Janney Montgomery Scott LLC bought a new position in shares of Elevance Health in the 4th quarter worth approximately $16,311,000. Mutual Advisors LLC raised its position in shares of Elevance Health by 2.5% in the 4th quarter. Mutual Advisors LLC now owns 2,163 shares of the company's stock worth $833,000 after acquiring an additional 52 shares in the last quarter. Avior Wealth Management LLC raised its position in shares of Elevance Health by 10.4% in the 4th quarter. Avior Wealth Management LLC now owns 1,300 shares of the company's stock worth $480,000 after acquiring an additional 122 shares in the last quarter. Finally, Inspire Investing LLC raised its position in shares of Elevance Health by 24.9% in the 4th quarter. Inspire Investing LLC now owns 2,842 shares of the company's stock worth $1,048,000 after acquiring an additional 566 shares in the last quarter. 89.24% of the stock is currently owned by hedge funds and other institutional investors.

Elevance Health Stock Performance

NYSE:ELV traded up $3.46 during mid-day trading on Tuesday, reaching $375.73. The stock had a trading volume of 1,938,372 shares, compared to its average volume of 1,528,673. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.50 and a current ratio of 1.45. The firm has a market capitalization of $84.89 billion, a price-to-earnings ratio of 14.67, a PEG ratio of 1.18 and a beta of 0.66. Elevance Health, Inc. has a twelve month low of $357.45 and a twelve month high of $567.26. The business has a 50 day simple moving average of $418.36 and a 200 day simple moving average of $402.34.

Elevance Health (NYSE:ELV - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The company reported $11.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $10.60 by $1.37. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%. The company had revenue of $48.77 billion during the quarter, compared to analysts' expectations of $46.26 billion. On average, analysts expect that Elevance Health, Inc. will post 33.96 earnings per share for the current fiscal year.

Elevance Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Tuesday, June 10th will be paid a dividend of $1.71 per share. The ex-dividend date is Tuesday, June 10th. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.82%. Elevance Health's dividend payout ratio (DPR) is 26.69%.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. Barclays raised their price objective on Elevance Health from $512.00 to $522.00 and gave the company an "overweight" rating in a research report on Wednesday, April 23rd. Mizuho lifted their target price on Elevance Health from $455.00 to $505.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Truist Financial raised their price target on Elevance Health from $480.00 to $510.00 and gave the stock a "buy" rating in a research note on Friday, April 11th. Cantor Fitzgerald restated an "overweight" rating and issued a $485.00 price target on shares of Elevance Health in a research note on Wednesday, April 23rd. Finally, Guggenheim reiterated a "buy" rating and set a $518.00 target price on shares of Elevance Health in a research report on Wednesday, April 23rd. Four research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $510.38.

Insider Transactions at Elevance Health

In other Elevance Health news, CAO Ronald W. Penczek sold 443 shares of Elevance Health stock in a transaction on Monday, March 10th. The shares were sold at an average price of $415.13, for a total value of $183,902.59. Following the transaction, the chief accounting officer now owns 1,847 shares in the company, valued at $766,745.11. This trade represents a 19.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Mark Kaye sold 4,588 shares of the business's stock in a transaction on Thursday, April 24th. The stock was sold at an average price of $424.82, for a total transaction of $1,949,074.16. Following the completion of the transaction, the chief financial officer now owns 18,977 shares in the company, valued at $8,061,809.14. This represents a 19.47% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 8,535 shares of company stock valued at $3,521,612 in the last ninety days. Corporate insiders own 0.29% of the company's stock.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.